000			01371 a2200445 4500
005			20250512090814.0
264		0	_c19720622
008			197206s 0 0 eng d
022			_a0140-6736
024	7		_a10.1016/s0140-6736(72)90740-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aDavis, S
245	0	0	_aTreatment and prognosis in aplastic anaemia. _h[electronic resource]
260			_bLancet (London, England) _cApr 1972
300			_a871-3 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAnemia, Aplastic _xcomplications
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aBacterial Infections _xmortality
650	0	4	_aBlood Transfusion
650	0	4	_aChild
650	0	4	_aFemale
650	0	4	_aFluoxymesterone _xtherapeutic use
650	0	4	_aHemorrhage _xmortality
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOxymetholone _xtherapeutic use
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aPrognosis
650	0	4	_aSex Factors
650	0	4	_aTime Factors
700	1		_aRubin, A D
773	0		_tLancet (London, England) _gvol. 1 _gno. 7756 _gp. 871-3
856	4	0	_uhttps://doi.org/10.1016/s0140-6736(72)90740-4 _zAvailable from publisher's website
999			_c4117469 _d4117469